Ethical considerations in digital biomarker adoption
The RADAR-AD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806999. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and Software AG. See www.imi.europa.eu for more details. This communication reflects the views of the RADAR-AD consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
Authors
- Federica Lucivero (ORCID: https://orcid.org/0000-0002-1308-5846)
- Dianne Gove (ORCID: https://orcid.org/0000-0002-4281-3494)
- Anna‐Katharine Brem
- Emma Poon
- Marie‐Christine Fritzsche
- Ana Diaz
- Dag Aarsland
Institutions
- King's College London (GB)
- Stavanger University Hospital (NO)
- University of Oxford (GB)
- Alzheimer Europe (LU)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_097030
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00